Triple-negative breast cancer (TNBC) is a subtype of breast cancer that lacks the expression of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2), and accounts for 15%-20% of all breast cancers (1, 2). Here, PGR is linked to breast carcinoma.